Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment

Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment

Abstract Preeclampsia is a disease of pregnancy associated with placental oxidative stress, inflammation and elevated release of anti-angiogenic factors sFlt-1 and soluble endoglin. These placental factors cause generalized maternal endothelial dysfunction. There are no treatments to halt disease pr...

Full description

Bibliographic Details
Main Authors: Natalie J. Hannan, Fiona C. Brownfoot, Ping Cannon, Minh Deo, Sally Beard, Tuong V. Nguyen, Kirsten R. Palmer, Stephen Tong, Tu’uhevaha J. Kaitu’u-Lino
Format: Article
Language:English
Published: Nature Publishing Group 2017-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-017-01993-w

Internet

https://doi.org/10.1038/s41598-017-01993-w

Similar Items